BMC Clinical Pharmacology

unofficial impact factor 1.36

Open Access Research article

Bioequivalence of HX575 (recombinant human epoetin alfa) and a comparator epoetin alfa after multiple intravenous administrations: an open-label randomised controlled trial

Fritz Sörgel*, Ursula Thyroff-Friesinger, Andrea Vetter, Bernhard Vens-Cappell and Martina Kinzig

BMC Clinical Pharmacology 2009, 9:10 doi:10.1186/1472-6904-9-10

Accesses  

  • Last 30 days: 138 accesses
  • Last 365 days: 1111 accesses
  • All time: 6245 accesses